Amazon Ordered by FDA to Stop Selling Multiple Eye Drops
[ad_1]
The U.S. Food and Drug Administration (FDA) sent a warning letter on November 13 to online retailer Amazon for selling non-FDA-approved eye drops on its site.
All of the products cited are homeopathic treatments. Homeopathic medicine is an alternative medical practice developed in the late 1700s, according to the FDA. Homeopathic treatments are often marketed as “natural” alternatives to conventional medications and treatments, and often are made from plants, minerals, and animal ingredients.
Some of the unapproved homeopathic eye drops were marketed for lubrication, while others claimed to treat pink eye and “floaters.”
The sale of these eye drops is concerning and poses potential harm to users, the letter says, “because the route of administration for these products bypasses some of the body’s natural defenses.”
The following unauthorized products were named by the FDA:
- Similasan Pink Eye Relief
- The Goodbye Company Pink Eye
- Can-C Eye Drops
- Optique 1 Eye Drops
- OcluMed Eye Drops
- TRP Natural Eyes Floaters Relief
- Manzanilla Sophia Chamomile Herbal Eye Drops
Amazon said in a statement that the products “have been investigated and are in the process of being removed,” according to reporting from the Washington Post. However, as of November 16, several of the products were still available on Amazon’s website.
The warning comes less than two weeks after the FDA recommended recalls for over two dozen brands of eye drops from major retailers, including CVS, Walmart, and Target, for possible contamination that could lead to infection or blindness.
No reports of injuries were cited in the FDA’s letter to Amazon.
[ad_2]
